content

Samsung Biologics Reports Fourth Quarter & Fiscal Year 2021 Financial Results

Samsung Biologics, the worldโ€™s leading contract development and manufacturing organization, announced strong financial results for the fourth quarter and record-high earnings for the fiscal...

Fermenta Biotech Limited exclusively licenses its proprietary enzymatic technology for manufacturing Molnupiravir to Aurigene Pharmaceutical

Fermenta Biotech Limitedย  announced that it has signed a Definitive Agreement with Aurigene Pharmaceutical Services Limited (APSL), a stepdown subsidiary of Dr Reddyโ€™s Laboratories...

Genezen appoints Senior Director of Business Development to support rapid growth

Genezen, Inc., a cell and gene therapy Contract Development and Manufacturing Organization (CDMO) focused on early-phase process development, GMP vector production and analytical testing...

19th Edition of BioAsia to focus on Future Readiness of the Life-Sciences Industry; 2-Day event to kick-start on February 24th

19th edition of the Asiaโ€™s largest life-sciences and Health Tech forum BioAsia, the annual flagship event of Government of Telangana will be held during...

Vetter’s Peter Soelkner featured on the โ€œMolecule to Marketโ€ podcast

Peter Soelkner featured on the โ€œMolecule to Marketโ€ podcast Peter Soelkner, one of the managing directors at Vetter, recently sat down with Raman Sehgal of...

Indian Pharmaceutical Industry Now And In The Days To Come

It shouldnโ€™t come as a surprise when we call India a global powerhouse when it comes to generic drugs. The Indian pharmaceutical companies cater...

Abzena appoints Jim Kennamer as SVP and Site Head of North Carolina

Abzena, a leading Partner Research Organization (PRO) for biopharmaceutical outsourced solutions from concept to clinic and into GMP manufacturing has announced the appointment of...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read